Phase I trial of ISIS APOCIIIRx in healthy volunteers.

Trial Profile

Phase I trial of ISIS APOCIIIRx in healthy volunteers.

Completed
Phase of Trial: Phase I

Latest Information Update: 27 Mar 2012

At a glance

  • Drugs Volanesorsen (Primary)
  • Indications Hypertriglyceridaemia
  • Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
  • Most Recent Events

    • 27 Mar 2012 Results presented at the 61st Annual Scientific Session of the American College of Cardiology.
    • 06 Dec 2011 Results were presented at the Cold Spring Harbor Laboratory 2(nd) RNA Therapeutics conference.
    • 06 Dec 2011 Status changed from recruiting to completed.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top